Tang Capital Management LLC Graphite Bio, Inc. Transaction History

Tang Capital Management LLC

  • $819 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.24 - $2.66 $909,787 - $1.08 Million
406,155 Added 19.47%
2,491,780 $6.53 Million
Q2 2023

Aug 14, 2023
BUY
$2.47 - $3.38 $141,182 - $193,197
57,159 Added 2.82%
2,085,625 $5.42 Million
Q1 2023

May 15, 2023
BUY
$1.85 - $3.21 $1.72 Million - $2.98 Million
928,466 Added 84.41%
2,028,466 $4.97 Million
Q2 2022

Aug 15, 2022
BUY
$2.14 - $5.23 $2.35 Million - $5.75 Million
1,100,000 New
1,100,000 $3.03 Million

Others Institutions Holding GRPH

# of Institutions
3
Shares Held
637K
Call Options Held
0
Put Options Held
0
View Full List

About Graphite Bio, Inc.

GRPH Quotes by TradingView
  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email